Arizona Pain, the premier pain management clinic in Phoenix, AZ, has been selected as the only Arizona pain center to participate in a novel study on chronic nerve pain. This FDA-approved study may unveil a potentially groundbreaking treatment with the use of a peripheral nerve stimulator, and patients who enroll today will be compensated.
September 20th, 2012, Scottsdale, AZ. — Those who suffer from debilitating chronic nerve pain will now have the chance to try a new, cutting-edge treatment that may rid them of their pain. Arizona Pain, (www.arizonapain.com) a comprehensive pain management clinic in the Phoenix area, is now enrolling patients for a breakthrough study involving the use of a new nerve stimulator to treat peripheral neuralgia — the Bioness StimRouter.
“The treatment we are testing in this study may finally provide lasting relief for patients suffering from intractable nerve pain,” says Arizona Pain’ Research Director, Dr. Ted Swing.
It is estimated that 20-million Americans suffer from peripheral nerve pain. Peripheral neuralgia refers to chronic pain of the arms, legs or trunk caused by damage to the nerves themselves. This condition can be the result of various causes, including physical trauma or surgical procedures, and is often difficult to treat. Current treatments include non-localized therapies such as spinal cord stimulation and the use of pain medication.
Bioness Inc., an award winning medical device company, is sponsoring this double blind, randomized study, which will enroll 126 patients at up to ten study sites throughout the United States. Patients who suffer from persistent nerve pain in their arms, legs or trunk, and who have been treated for more than three months without relief, may qualify for this study. It is free to participate, and all those who enroll will be financially compensated.
The study tests one method that has been previously effective for treating peripheral neuralgia — peripheral nerve stimulation. Through peripheral nerve stimulation, pain is reduced by delivering non-painful electrical stimulation to the nerve that is the source of an individual’s pain. This stimulation interferes with the pain signals from the affected nerve, resulting in a reduction in perceived pain.
8 thoughts on “Arizona Pain Studying New Chronic Nerve Pain Treatment”
I have severe diabetic neuropathy and gastroparesis once a day my stomach is full day. I need something that’s going to help me manage the pain Lyrica doesn’t work they give me suicidal thoughts and I’m Happy Lucky go guy. I need something that will help me remove some of the pain so I can get ou my bed? I can make an appointment and find out where I can do?
Hi David — You can make an appointment at https://arizonapain.com/contact/request-a-call-back/.
Please let me know how I can sign up for the study and see how I can qualify for the study I would like to find releif from the horrible feet pain I suffer from. I have MRI of my brain,neck,lower back, and right ankle. And also a new emg test results. My foot Dr said there is nothing anyone could do and I have to learn to live with it.
I have pain in my feet mostly tingling, burning, spasms, no balance and in wheelchair for 7 + years
Does Az Pain do he Bioness StemRouter? I had a bi-portal endoscopic discectomy at L4/L5 level. I awoke during surgery raising up on elbows. Equipment must have compressed L3 nerve because I’m left with severe burning under both knee caps. Neuropathy in feet and legs. Lots of abdominal and bowel pain and distress from opiates and years of laxatives, play into that too.
I’m in desperate pain and bedridden most of the time due to pain.
Very interested in Bioness StemRouter and if it can work for me. Can you help me?
Hi there — Unfortunately we can’t answer specific medical questions on the blog. You can contact our pain clinic at https://arizonapain.com/contact/ or request a call back at https://arizonapain.com/contact/request-a-call-back/.
Do you take Mercy Care
Hi Jamie — You can find all of our insurance information here: https://arizonapain.com/insurance-infomation/.
Comments are closed.